Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 1;13(1):e2023042.
doi: 10.5826/dpc.1301a42.

Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects?

Claudio Conforti  1 , Carmen Dell'Aquila  2 , Daniele Tognetto  2 , Iris Zalaudek  1 , Nicola Di Meo  1
Affiliations

Eyelid Lentigo Maligna Treated With Imiquimod 5%: Should We Fear of Ocular Side Effects?

Claudio Conforti et al. Dermatol Pract Concept. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None.

Figures

Figure 1
Figure 1
A brownish macule of about 6-mm located on the lower eyelid was observed. [Fig.1A] Dermoscopic evaluation showed a brown pseudo-network with intense pigmentation and obliterations of follicles. [Fig 1B]. After 4 weeks of treatment with imiquimod 5%, a partial response was observed [Fig1C, Fig1D] and after 6 weeks a complete response was achieved. [Fig1E, Fig1F]
See this image and copyright information in PMC

References

    1. Lallas A, Moscarella E, Kittler H, et al. Real-world experience of off-label use of imiquimod 5% as an adjuvant therapy after surgery or as a monotherapy for lentigo maligna. Br J Dermatol. 2021;185(3):675–677. doi: 10.1111/bjd.20407. - DOI - PubMed
    1. Hamilko de Barros M, Conforti C, Giuffrida R, Seabra Resende FS, Di Meo N, Zalaudek I. Clinical usefulness of dermoscopy in the management of lentigo maligna melanoma treated with topical imiquimod: A case report. Dermatol Ther. 2019;32(5):e13048. doi: 10.1111/dth.13048. - DOI - PubMed
    1. O’Neill J, Ayers D, Kenealy J. Periocular lentigo maligna treated with imiquimod. J Dermatolog Treat. 2011;22(2):109–112. doi: 10.3109/09546630903559798. - DOI - PubMed
    1. Elia MD, Lally SE, Hanlon AM, et al. Periocular Melanoma In Situ Treated With Imiquimod. Ophthalmic Plast Reconstr Surg. 2016 Sep–Oct;32(5):371–373. doi: 10.1097/IOP.0000000000000554. - DOI - PubMed
    1. Murchison AP, Washington CV, Soloman AR, Bernardino CR. Ocular effects of imiquimod with treatment of eyelid melanoma in situ. Dermatol Surg. 2007;33:1136–1138. doi: 10.1111/j.1524-4725.2007.33232.x. - DOI - PubMed

LinkOut - more resources